Home > Insider Trading > Filing (0000950170-24-115723)

Filing Details

Accession Number:: 0000950170-24-115723
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-18 19:43:18
Reporting Period:: 2024-10-17

Accepted Time:: 2024-10-18 19:43:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703647	Korro Bio Inc.	KRRO	Pharmaceutical Preparations (2834)	472324450

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1997973	Vineet Agarwal	C/O Korro Bio, Inc. 60 First Street, 2Nd Floor, Suite 250 Cambridge MA 02141	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-10-17	9,263	$11.68	9,263	No	4	M	Direct
Common Stock	Acquisiton	2024-10-17	953	$14.98	10,216	No	4	M	Direct
Common Stock	Disposition	2024-10-17	2,023	$71.51	8,193	No	4	S	Direct
Common Stock	Disposition	2024-10-17	164	$73.71	8,029	No	4	S	Direct
Common Stock	Disposition	2024-10-17	115	$74.56	7,914	No	4	S	Direct
Common Stock	Disposition	2024-10-17	56	$76.00	7,858	No	4	S	Direct
Common Stock	Disposition	2024-10-17	23	$77.00	7,835	No	4	S	Direct
Common Stock	Disposition	2024-10-17	260	$77.55	7,575	No	4	S	Direct
Common Stock	Disposition	2024-10-17	457	$78.59	7,118	No	4	S	Direct
Common Stock	Disposition	2024-10-17	1,815	$79.79	5,303	No	4	S	Direct
Common Stock	Disposition	2024-10-17	4,961	$80.50	342	No	4	S	Direct
Common Stock	Disposition	2024-10-17	317	$81.48	25	No	4	S	Direct
Common Stock	Disposition	2024-10-17	25	$82.89	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-10-17	9,263	$0.00	9,263	$11.68
Common Stock	Stock Option (Right to Buy)	Disposition	2024-10-17	953	$0.00	953	$14.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,607		2031-05-29	No	4	M	Direct
45,594		2033-11-02	No	4	M	Direct

Footnotes

The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.965 to $71.94, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.30 to $73.975, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.51 to $74.90, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.01 to $78.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.07 to $78.935, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.12 to $80.115, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.15 to $81.14, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.20 to $82.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
The shares subject to the option vest in 48 equal monthly installments commencing from November 3, 2023, subject to the Reporting Person's continued service on each such vesting date.